Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Mortality in Mechanically Ventilated Myasthenia Gravis Adult Patients: Comparing Intravenous Immunoglobulin vs Steroids

Author:Mandava, Kranthi   Jaffry, Kazim   Jaffry, Mustafa   Shaikh, Anam   Trivedi, Ronak   Ors, Muhammed   Faiz, Iqra   Mohammed Ali, Reza   Mostafa, Fahad   Khan, Hafiz   Souayah, Nizar   

Session Name:P1: Autoimmune Neurology: Myasthenia Gravis  

Topic:Autoimmune Neurology  

Program Number:P1.010  

Author Institution:New Jersey Medical School, Highland Park, NJ  New Jersey Medical School, Edison, NJ  New Jersey Medical School, North Brunswick, NJ  New Jersey Medical School, Red Bank, NJ  New Jersey Medical School, Newark, NJ  Texas Tech University, Lubbock, TX  Texas Tech University Health Sciences Center, Lubbock, TX  New Jersey Medical School, Westfield, NJ  

Structured Early Advanced Care Planning Outcomes for Patients with High Grade Glioma

Author:Pescatello, Meredith   Mohile, Nimish   Serventi, Jennifer   Sayers, Bethann   Behr, Jacqueline   Hemminger, Lauryn   Hardy, Sara   

Session Name:S17: Innovations in Neuro-oncology  

Topic:Neuro-oncology  

Program Number:S17.006  

Author Institution:University of Rochester, Wilmot Cancer Center, Rochester, NY  

Integrated safety summary from Phase 3 clinical trials of IPX203, an extended-release carbidopa-levodopa formulation, in Parkinson disease

Author:Fernandez, Hubert   Hauser, Robert   Hinson, Vanessa   Pavasia, Nirav   Molho, Eric   Zeitlin, Leonid   Visser, Hester   D'Souza, Richard   

Session Name:P1: Movement Disorders: Clinical Trials in Parkinson's Disease 1  

Topic:Movement Disorders  

Program Number:P1.006  

Author Institution:Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH  Movement Disorders Center, Tampa, FL  MUSC, Charleston, SC  Neurology Consultants of Dallas, Dallas, TX  Parkinson's Disease & Movement Dis Ctr, Albany, NY  Quartesian LLC, Princeton, NJ  Amneal Pharmaceuticals, Piscataway, NJ  Amneal Pharmaceuticals, Bridgewater, NJ  

Autologous hematopoietic stem cell transplantation in multiple sclerosis: A 20-year single center's experience in Mexico.

Author:Rodriguez Estrada, Mario Enrique   Molina Carrion, Luis   

Session Name:P14: MS Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P14.015  

Author Institution:National Medical Center " La Raza" of the Mexican Social Security Institute, Mexico City, Mexico  

NfL as a Predictor of GdE Lesions in Patients With Relapsing Multiple Sclerosis Treated With Ozanimod in the Phase 2 RADIANCE Trial

Author:Harris, Sarah   Vermersch, Patrick   Montalban, Xavier   Hartung, Hans-Peter   Kappos, Ludwig   Southworth, Harry   Sheffield, James K.   Silva, Diego   Cohen, Jeffrey A.   

Session Name:P1: MS Biomarkers  

Topic:MS and Inflammatory Disease  

Program Number:P1.012  

Author Institution:Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Univ. Lille, Inserm UMR U1172, CHU Lille, FHU Precise, Lille, France, Lille, France  Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain  Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany  Brain and Mind Centre, University of Sydney, Sydney, Australia  Department of Neurology, Medical University of Vienna, Vienna, Austria  and Palacký University Olomouc, Olomouc, Czech Republic, Olomouc, Czech Republic  Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland  Data Clarity Consulting Ltd, Stockport, England, United Kingdom, England, United Kingdom  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH